Table 2.
Step 1-Covariates | b | SE | p | OR | 95% CI (OR) |
---|---|---|---|---|---|
age | −.022 | .014 | .109 | .979 | .953,1.01 |
gender | −.338 | .365 | .354 | .713 | .348, 1.46 |
race (Black vs. White) | .172 | .347 | .621 | 1.187 | .601, 2.34 |
race (Other vs. White) | −.641 | 1.106 | .562 | .527 | .060, 4.60 |
site (site 3 vs. 1) | −.066 | .438 | .879 | .936 | .397, 2.21 |
site (site 2 vs. 1) | .530 | .473 | .262 | 1.699 | .673, 4.29 |
NYHA functional class | .721 | .210 | .001 | 2.057 | 1.364, 3.10 |
Step 2-Predictors | |||||
age | −.019 | .017 | .248 | .981 | .949, 1.01 |
gender | −.350 | .460 | .447 | .705 | .287, 1.74 |
race (Black vs. White) | .154 | .474 | .746 | 1.166 | .461, 2.95 |
race (Other vs. White) | −1.013 | 1.236 | .412 | .363 | .0322, 4.09 |
site (site 3 vs. 1) | −.434 | .538 | .420 | .648 | .226, 1.86 |
site (site 2 vs. 1) | .383 | .585 | .513 | 1.467 | .466, 4.62 |
NYHA functional class | .454 | .236 | .054 | 1.575 | .992, 2.50 |
Total number of prescription drugs | −.033 | .062 | .589 | .967 | .857, 1.09 |
Number of Drugs Cause Daytime Somnolence | .733 | .233 | .002 | 2.082 | 1.33, 3.29 |
Treatment quality score | .402 | .958 | .674 | 1.496 | .229, 9.77 |
Systolic blood pressure | −.019 | .011 | .089 | .982 | .961, 1.00 |
Waist circumference | −.002 | .012 | .863 | .998 | .976, 1.02 |
Sleep Disordered Breathing | .084 | .413 | .839 | 1.088 | .484, 2.45 |
Exercise | −.186 | .131 | .155 | .830 | .642, 1.07 |
Alcohol consumption | −.297 | .260 | .253 | .743 | .447, 1.24 |
Smoking history | −.424 | .298 | .155 | .654 | .365, 1.17 |
Sleep hygiene | .334 | .103 | .001 | 1.397 | 1.14, 1.71 |
Depression (PHQ-2) | .602 | .177 | .001 | 1.827 | 1.29, 2.59 |
Perceived overall health | .495 | .241 | .040 | 1.641 | 1.02, 2.63 |
MSPSS total social support score | .006 | .016 | .710 | 1.006 | .975, 1.04 |
Note: b =logit; parameter estimates derived from each step
OR = Odds Ratio
MSPSS = Multidimensional Scale of Perceived Social Support; PHQ-2 = Patient Health Questionnaire